Unknown

Dataset Information

Stage and disease-free interval help select patients for surgical management of locally recurrent and metastatic adrenocortical carcinoma.


ABSTRACT:

Background and objectives

Chemotherapeutic options for patients with recurrent/metastatic adrenocortical carcinoma (ACC) are limited, leading to consideration for surgical management. We sought to determine characteristics associated with an unequivocal survival benefit amongst patients undergoing re-resection or metastasectomy.

Methods

Patients who underwent surgery for recurrent/metastatic ACC were identified and stratified into two groups: those with postoperative survival comparable with what has been reported with chemotherapy alone (<12 months) and those surviving twice that duration (>24 months). Those who survived between 12 and 24 months were excluded, as the objective was to characterize patients who most distinctly benefited from resection. Clinicopathologic and t

SUBMITTER: Lo W 

PROVIDER: S-EPMC8189166 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature